Xbiotech Inc. (XBIT) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Xbiotech Inc.

CIK: 1626878 Ticker: XBIT

View differences made from one to another to evaluate Xbiotech Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Xbiotech Inc..


Assess how Xbiotech Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Xbiotech Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Xbiotech Inc. provided additional information to their SEC Filing as exhibits

Ticker: XBIT
CIK: 1626878
Form Type: 8-K Corporate News
Accession Number: 0001171843-18-007152
Submitted to the SEC: Wed Oct 24 2018 12:08:52 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Wednesday, October 24, 2018
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: